Sloy Dahl & Holst’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,044	Closed	-$223K	–	116
2025 Q3	$223K	Buy	+8,044	New	+$203K	0.02%	105
2024 Q4	–	Sell	-12,465	Closed	-$319K	–	110
2024 Q3	$319K	Sell	12,465 -2,508	-17%	-$63.9K	0.05%	73
2024 Q2	$352K	Buy	14,973 +1,723	+13%	+$43.5K	0.07%	62
2024 Q1	$381K	Sell	13,250 -242	-2%	-$7.28K	0.09%	58
2023 Q4	$443K	Buy	13,492 +2,079	+18%	+$56.5K	0.09%	54
2023 Q3	$318K	Buy	11,413 +1,131	+11%	+$37K	0.07%	61
2023 Q2	$351K	Sell	10,282 -215	-2%	-$6.76K	0.06%	56
2023 Q1	$316K	Buy	10,497 +175	+2%	+$5.42K	0.07%	48
2022 Q4	$291K	Sell	10,322 -1,349	-12%	-$42.8K	0.1%	50
2022 Q3	$384K	Buy	11,671 +1,379	+13%	+$50.6K	0.08%	49
2022 Q2	$324K	Buy	10,292 +1,761	+21%	+$61.6K	0.08%	52
2022 Q1	$392K	Buy	8,531 +26	+0.3%	+$1.24K	0.07%	48
2021 Q4	$635K	Hold	8,505	–	–	0.14%	40
2021 Q3	$635K	Sell	8,505 -1,421,578	-99%	-$119M	0.14%	40
2021 Q2	$132M	Buy	1,430,083 +70,915	+5%	+$6.03M	17.79%	3
2021 Q1	$121M	Buy	+1,359,168	New	+$135M	17.25%	3